Intellectual Property India Publishes Patent Application for 'Enzyme-Triggered Self-Immolative Prodrug System For Targeted And Controlled Chemotherapy' Filed by Panipat Institute Of Engineering And Technology

MUMBAI, India, April 17 -- Intellectual Property India has published a patent application (202611022899 A) filed by Panipat Institute Of Engineering And Technology, Samalkha, Haryana, on Feb. 26, for 'enzyme-triggered self-immolative prodrug system for targeted and controlled chemotherapy.'

Inventor(s) include Prof. Daisy Arora; Prof. Parveen Kumar Goyal; Dr. Arti Soni; and Sakshi Garg.

The application for the patent was published on April 17, under issue no. 16/2026.

According to the abstract released by the Intellectual Property India: "An enzyme-triggered self-immolative prodrug system for targeted chemotherapy is disclosed, comprising a therapeutic agent, a self-immolative linker, and an enzyme-cleavable triggering moiety. The prodru...